Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lepri

Showing results (661-670 of 959) with videos related to

Pageof 96
Sort By:
Journal of the International AIDS Society|November 15, 2014
Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in ItalyAlessandro Cozzi-Lepri, Sergio Lo Caputo, Franco Maggiolo, et al.
Open Forum Infectious Diseases|January 15, 2021
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected PatientsVincenzo Malagnino, Carlotta Cerva, Antonella Cingolani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2010
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort studyM C F Prosperi, A Cozzi-Lepri, A Castagna, et al.
Viruses|August 26, 2022
SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWHAlessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali, et al.
Viruses|August 10, 2021
Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort StudyMartina Spaziante, Gloria Taliani, Giulia Marchetti, et al.
Archives of Internal Medicine|October 11, 2002
Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjectsAndrea De Luca, Roberto Bugarini, Alessandro Cozzi Lepri, et al.
American Journal of Medical Genetics. Part A|August 5, 2011
Ebstein anomaly: Genetic heterogeneity and association with microdeletions 1p36 and 8p23.1Maria Cristina Digilio, Laura Bernardini, Francesca Lepri, et al.
The Journal of Infectious Diseases|May 15, 2004
Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor antiretroviral regimens failedCarlo Federico Perno, Alessandro Cozzi-Lepri, Federica Forbici, et al.
Antiviral Therapy|March 9, 2005
Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individualsGiorgio Antonucci, Enrico Girardi, Alessandro Cozzi-Lepri, et al.
BMC Medical Genetics|September 6, 2015
Spinal ependymoma in a patient with Kabuki syndrome: a case reportDavide Roma, Paolo Palma, Rossella Capolino, et al.
Pageof 96

Showing results (661-670 of 959) with videos related to

Sort By:
Pageof 96
Journal of the International AIDS Society|November 15, 2014
Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in ItalyAlessandro Cozzi-Lepri, Sergio Lo Caputo, Franco Maggiolo, et al.
Open Forum Infectious Diseases|January 15, 2021
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected PatientsVincenzo Malagnino, Carlotta Cerva, Antonella Cingolani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2010
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort studyM C F Prosperi, A Cozzi-Lepri, A Castagna, et al.
Viruses|August 26, 2022
SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWHAlessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali, et al.
Viruses|August 10, 2021
Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort StudyMartina Spaziante, Gloria Taliani, Giulia Marchetti, et al.
Archives of Internal Medicine|October 11, 2002
Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjectsAndrea De Luca, Roberto Bugarini, Alessandro Cozzi Lepri, et al.
American Journal of Medical Genetics. Part A|August 5, 2011
Ebstein anomaly: Genetic heterogeneity and association with microdeletions 1p36 and 8p23.1Maria Cristina Digilio, Laura Bernardini, Francesca Lepri, et al.
The Journal of Infectious Diseases|May 15, 2004
Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor antiretroviral regimens failedCarlo Federico Perno, Alessandro Cozzi-Lepri, Federica Forbici, et al.
Antiviral Therapy|March 9, 2005
Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individualsGiorgio Antonucci, Enrico Girardi, Alessandro Cozzi-Lepri, et al.
BMC Medical Genetics|September 6, 2015
Spinal ependymoma in a patient with Kabuki syndrome: a case reportDavide Roma, Paolo Palma, Rossella Capolino, et al.
Pageof 96